Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00480025

Public ClinicalTrials.gov record NCT00480025. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 7:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Resectable MAGE-A3 Positive Non-Small Cell Lung Cancer

Study identification

NCT ID
NCT00480025
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
2,278 participants

Conditions and interventions

Interventions

  • GSK1572932A Antigen-Specific Cancer Immunotherapeutic Biological
  • Placebo Control Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 3, 2007
Primary completion
Dec 5, 2013
Completion
Sep 22, 2014
Last update posted
Dec 21, 2020

2007 – 2014

United States locations

U.S. sites
201
U.S. states
41
U.S. cities
160
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35294-3300
GSK Investigational Site Mobile Alabama 36604
GSK Investigational Site Mobile Alabama 36608
GSK Investigational Site Phoenix Arizona 85013
GSK Investigational Site Scottsdale Arizona 85258
GSK Investigational Site Scottsdale Arizona 85259
GSK Investigational Site Tucson Arizona 85724
GSK Investigational Site Fayetteville Arkansas 72703
GSK Investigational Site Fort Smith Arkansas 72917
GSK Investigational Site Jonesboro Arkansas 72401
GSK Investigational Site Bakersfield California 93309
GSK Investigational Site Beverly Hills California 90211
GSK Investigational Site Burbank California 91505
GSK Investigational Site Duarte California 91010
GSK Investigational Site Fresno California 93720
GSK Investigational Site Greenbrae California 94904-2007
GSK Investigational Site La Jolla California 92093-0987
GSK Investigational Site La Jolla California 92093
GSK Investigational Site Los Angeles California 90095
GSK Investigational Site Montebello California 90640
GSK Investigational Site Orange California 92868
GSK Investigational Site Palm Springs California 92262
GSK Investigational Site Palo Alto California 94304
GSK Investigational Site Pleasant Hill California 94523
GSK Investigational Site Rancho Mirage California 92270
GSK Investigational Site Sacramento California 95816
GSK Investigational Site Sacramento California 95817
GSK Investigational Site San Diego California 92121
GSK Investigational Site San Diego California 92123
GSK Investigational Site San Francisco California 94107
GSK Investigational Site Santa Rosa California 95403-1757
GSK Investigational Site Stanford California 94305
GSK Investigational Site Vallejo California 94589
GSK Investigational Site West Hollywood California 90048
GSK Investigational Site Aurora Colorado 80045
GSK Investigational Site Colorado Springs Colorado 80907
GSK Investigational Site Danbury Connecticut 06810
GSK Investigational Site Torrington Connecticut 06790
GSK Investigational Site Waterbury Connecticut 06708
GSK Investigational Site Newark Delaware 19713
GSK Investigational Site Washington D.C. District of Columbia 20007
GSK Investigational Site Boca Raton Florida 33486
GSK Investigational Site Boynton Beach Florida 33435
GSK Investigational Site Deerfield Beach Florida 33064
GSK Investigational Site Fort Lauderdale Florida 33316
GSK Investigational Site Hollywood Florida 33021
GSK Investigational Site Jacksonville Florida 32209
GSK Investigational Site Ocala Florida 34474
GSK Investigational Site Orlando Florida 32804
GSK Investigational Site Orlando Florida 32806
GSK Investigational Site Stuart Florida 34994
GSK Investigational Site Tampa Florida 33606
GSK Investigational Site West Palm Beach Florida 33401
GSK Investigational Site Alpharetta Georgia 30005
GSK Investigational Site Athens Georgia 30607
GSK Investigational Site Atlanta Georgia 30318
GSK Investigational Site Atlanta Georgia 30322
GSK Investigational Site Atlanta Georgia 30342
GSK Investigational Site Augusta Georgia 30901
GSK Investigational Site Macon Georgia 31201
GSK Investigational Site Marietta Georgia 30060
GSK Investigational Site Savannah Georgia 31405
GSK Investigational Site Honolulu Hawaii 96813
GSK Investigational Site Coeur d'Alene Idaho 83814
GSK Investigational Site Chicago Illinois 60611
GSK Investigational Site Chicago Illinois 60612
GSK Investigational Site Chicago Illinois 60637
GSK Investigational Site Decatur Illinois 62526
GSK Investigational Site Evanston Illinois 60201
GSK Investigational Site Harvey Illinois 60426
GSK Investigational Site Park Ridge Illinois 60068
GSK Investigational Site Peoria Illinois 61615-7822
GSK Investigational Site Springfield Illinois 62794-9638
GSK Investigational Site Evansville Indiana 47713
GSK Investigational Site Indianapolis Indiana 46260
GSK Investigational Site Indianapolis Indiana
GSK Investigational Site Munster Indiana 46321
GSK Investigational Site New Albany Indiana 47150
GSK Investigational Site Waterloo Iowa 50701
GSK Investigational Site Ashland Kentucky 41101
GSK Investigational Site Hazard Kentucky 41701
GSK Investigational Site Lexington Kentucky 40503
GSK Investigational Site Louisville Kentucky 40245
GSK Investigational Site Owensboro Kentucky 42303
GSK Investigational Site Alexandria Louisiana 71301
GSK Investigational Site Metairie Louisiana 70006
GSK Investigational Site Shreveport Louisiana 71101
GSK Investigational Site Annapolis Maryland 21401
GSK Investigational Site Baltimore Maryland 21201
GSK Investigational Site Baltimore Maryland 21204
GSK Investigational Site Baltimore Maryland 21215
GSK Investigational Site Baltimore Maryland 21237
GSK Investigational Site Bethesda Maryland 20892-1201
GSK Investigational Site Silver Spring Maryland 20902
GSK Investigational Site Towson Maryland 21204
GSK Investigational Site Boston Massachusetts 02111
GSK Investigational Site Boston Massachusetts 02114
GSK Investigational Site Boston Massachusetts 02118
GSK Investigational Site Worcester Massachusetts 01605
GSK Investigational Site Worcester Massachusetts 01608
GSK Investigational Site Ann Arbor Michigan 48109
GSK Investigational Site Bay City Michigan 48706
GSK Investigational Site Detroit Michigan 48201
GSK Investigational Site Detroit Michigan 48202
GSK Investigational Site Flint Michigan 48503
GSK Investigational Site Grand Rapids Michigan 49503
GSK Investigational Site Lansing Michigan 48910
GSK Investigational Site Lapeer Michigan 48446
GSK Investigational Site Southfield Michigan 48075
GSK Investigational Site Minneapolis Minnesota 55407-3799
GSK Investigational Site Minneapolis Minnesota 55455
GSK Investigational Site Rochester Minnesota 55905
GSK Investigational Site Saint Louis Park Minnesota 55416
GSK Investigational Site Saint Louis Park Minnesota 55426
GSK Investigational Site Kansas City Missouri 64111
GSK Investigational Site Kansas City Missouri 64132
GSK Investigational Site Springfield Missouri 65804
GSK Investigational Site St Louis Missouri 63110
GSK Investigational Site Billings Montana 59102
GSK Investigational Site Grand Island Nebraska 68803
GSK Investigational Site Omaha Nebraska 68114
GSK Investigational Site Henderson Nevada 89052
GSK Investigational Site Lebanon New Hampshire 03756
GSK Investigational Site Long Branch New Jersey 07740
GSK Investigational Site Paramus New Jersey 07652
GSK Investigational Site Armonk New York 10504
GSK Investigational Site Buffalo New York 14263
GSK Investigational Site East Syracuse New York 13057
GSK Investigational Site Flushing New York 11355
GSK Investigational Site Mineola New York 11501
GSK Investigational Site New York New York 10003
GSK Investigational Site New York New York 10011
GSK Investigational Site New York New York 10016
GSK Investigational Site New York New York 10019
GSK Investigational Site New York New York 10032
GSK Investigational Site New York New York 10065
GSK Investigational Site Syracuse New York 13210
GSK Investigational Site Chapel Hill North Carolina 27599-7065
GSK Investigational Site Charlotte North Carolina 28203
GSK Investigational Site Charlotte North Carolina 28204
GSK Investigational Site Durham North Carolina 27705
GSK Investigational Site Durham North Carolina 27710
GSK Investigational Site Greenville North Carolina 27834
GSK Investigational Site Akron Ohio 44304
GSK Investigational Site Canton Ohio 44710
GSK Investigational Site Cincinnati Ohio 45242
GSK Investigational Site Cincinnati Ohio 45267
GSK Investigational Site Columbus Ohio 43210
GSK Investigational Site Dayton Ohio 45429
GSK Investigational Site Tulsa Oklahoma 74136
GSK Investigational Site Bend Oregon 97701
GSK Investigational Site Portland Oregon 97213
GSK Investigational Site Bethlehem Pennsylvania 18015
GSK Investigational Site Danville Pennsylvania 17822
GSK Investigational Site Lancaster Pennsylvania 17605
GSK Investigational Site Langhorne Pennsylvania 19047
GSK Investigational Site Philadelphia Pennsylvania 19104
GSK Investigational Site Philadelphia Pennsylvania 19111
GSK Investigational Site Philadelphia Pennsylvania 19140
GSK Investigational Site Pittsburgh Pennsylvania 15212
GSK Investigational Site Pittsburgh Pennsylvania 15232
GSK Investigational Site Sayre Pennsylvania 18840
GSK Investigational Site Wilkes-Barre Pennsylvania 18702
GSK Investigational Site Willow Grove Pennsylvania 19090
GSK Investigational Site Providence Rhode Island 02903
GSK Investigational Site Providence Rhode Island 02906
GSK Investigational Site Charleston South Carolina 29414
GSK Investigational Site Charleston South Carolina 29425
GSK Investigational Site Columbia South Carolina 29209
GSK Investigational Site Greenville South Carolina 29615
GSK Investigational Site Spartanburg South Carolina 29303
GSK Investigational Site Sumter South Carolina 29150
GSK Investigational Site Chattanooga Tennessee 37421
GSK Investigational Site Cookeville Tennessee 38501
GSK Investigational Site Knoxville Tennessee 37905
GSK Investigational Site Knoxville Tennessee 37920
GSK Investigational Site Memphis Tennessee 38104
GSK Investigational Site Memphis Tennessee 38120
GSK Investigational Site Nashville Tennessee 37203
GSK Investigational Site Amarillo Texas 79106
GSK Investigational Site Dallas Texas 75230
GSK Investigational Site Dallas Texas 75231
GSK Investigational Site Dallas Texas 75246
GSK Investigational Site Grapevine Texas 76051
GSK Investigational Site Houston Texas 77030
GSK Investigational Site Houston Texas 77090
GSK Investigational Site Round Rock Texas 78665
GSK Investigational Site Tyler Texas 75708-3154
GSK Investigational Site Ogden Utah 84403
GSK Investigational Site Salt Lake City Utah 84106
GSK Investigational Site Fairfax Virginia 22031
GSK Investigational Site Roanoke Virginia 24014
GSK Investigational Site Everett Washington 98201
GSK Investigational Site Seattle Washington 98104
GSK Investigational Site Seattle Washington 98108
GSK Investigational Site Seattle Washington 98109
GSK Investigational Site Spokane Washington 99208
GSK Investigational Site Tacoma Washington 98405
GSK Investigational Site Vancouver Washington 98664
GSK Investigational Site Madison Wisconsin 53792
GSK Investigational Site Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 419 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00480025, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2020 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00480025 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →